sub:assertion {
d:DB00169 dv:ddi-interactor-in dr:DB00169_DB06723 .
d:DB06723 dv:ddi-interactor-in dr:DB00169_DB06723 .
dr:DB00169_DB06723 dct:identifier "drugbank_resource:DB00169_DB06723" ;
dct:title "DDI between Cholecalciferol and Aluminum hydroxide - Vitamin D analogs such as cholecalciferol may increase the serum concentration of aluminum hydroxide. Specifically, the absorption of aluminum may be increased, leading to increased serum aluminum concentrations. Avoid chronic and/or excessive use of aluminum and aluminum-containing products in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities."@en ;
a dv:Drug-Drug-Interaction ;
rdfs:label "DDI between Cholecalciferol and Aluminum hydroxide - Vitamin D analogs such as cholecalciferol may increase the serum concentration of aluminum hydroxide. Specifically, the absorption of aluminum may be increased, leading to increased serum aluminum concentrations. Avoid chronic and/or excessive use of aluminum and aluminum-containing products in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities. [drugbank_resource:DB00169_DB06723]"@en .
}